Sutro Biopharma, Inc. (FRA:S090)

Sutro Biopharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	90	147	237	435	605	808
Market Cap Growth	-39.60%	-38.05%	-45.56%	-28.22%	-25.04%	256.82%
Enterprise Value	-39	-204	-50	181	398	598
Last Close Price	9.67	17.80	38.80	72.50	130.00	172.00
PS Ratio	0.99	2.44	1.70	6.85	11.13	23.12
PB Ratio	-1.20	3.40	1.75	2.14	2.73	2.98
P/TBV Ratio	-	3.40	1.75	2.14	2.73	2.98
P/OCF Ratio	-	-	-	130.85	-	-
EV/Sales Ratio	-	-	-	2.85	7.32	17.11
EV/FCF Ratio	0.20	-	-	-	-	-
Debt / Equity Ratio	-0.20	0.52	0.23	0.23	0.23	0.07
Asset Turnover	0.32	0.14	0.35	0.18	0.17	0.16
Quick Ratio	2.39	2.47	4.39	5.13	5.04	12.63
Current Ratio	2.53	2.60	4.50	5.31	5.24	12.78
Return on Equity (ROE)	-1810.01%	-234.19%	-58.25%	-50.77%	-36.10%	-14.95%
Return on Assets (ROA)	-25.80%	-34.74%	-12.72%	-21.54%	-16.74%	-16.13%
Return on Capital (ROIC)	-256.77%	-118.73%	-24.76%	-27.91%	-18.48%	-19.13%
Return on Capital Employed (ROCE)	-99.10%	-93.40%	-23.70%	-37.90%	-32.90%	-19.50%
Earnings Yield	-206.25%	-149.92%	-40.84%	-25.67%	-15.33%	-3.25%
FCF Yield	-214.20%	-128.28%	-44.34%	-0.93%	-14.09%	-7.58%
Buyback Yield / Dilution	-17.26%	-27.70%	-18.57%	-10.02%	-41.59%	-41.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.